What it is
Loratadine is a second-generation H1 antihistamine, available without a prescription in Spain. It is one of the most dispensed antihistamines in the world because of its safety profile: effective against allergy symptoms with minimal sedation and a 24-hour duration.
Its active metabolite, desloratadine, is also marketed as an active substance in its own right, with a very similar profile.
Selective blockade of the peripheral H1 receptor
Loratadine competitively blocks histamine H1 receptors:
- It blocks peripheral H1 receptors → it reduces itching, sneezing, runny nose and watery eyes.
- It barely reaches the brain (P-glycoprotein pumps it out at the blood–brain barrier) → minimal sedation.
- It has no relevant anticholinergic effect: no dry mouth or urinary retention.
- It is not a bronchodilator: it does not treat the bronchospasm of allergic asthma.
- It acts on established symptoms but also has a preventive effect if taken before allergen exposure.
At the counter
When to recommend it
- Seasonal (pollen) or perennial (dust mites, pet hair) allergic rhinitis
- Acute and chronic urticaria
- Allergic conjunctivitis (add antihistamine eye drops for better eye relief)
- Allergic contact dermatitis with itching
- First option for people with allergies who drive or operate machinery
- In pregnancy and breastfeeding it is one of the antihistamines with the most data (the decision is the doctor's)
When not to
- It does not work in severe food allergies or anaphylaxis (adrenaline is needed)
- It is not a bronchodilator: it does not replace salbutamol in an asthma attack
- In severe urticaria a higher dose or a combination may be needed: that requires medical assessment
- It is not the first option if a sedative effect is wanted (for example, intense night-time itching that prevents sleep)
Warnings
- Caution GRAPEFRUIT: grapefruit juice inhibits CYP3A4 and can raise loratadine levels. Although the clinical effect is mild, tell the patient.
- Caution LIVER FAILURE: in severe liver disease, the dose is given on alternate days.
- Worth knowing INDIVIDUAL SEDATION: although statistically non-sedating, a small proportion of patients report drowsiness. If it happens, consider switching to bilastine or desloratadine.
- Worth knowing VARIABLE EFFICACY: in severe allergic rhinitis or chronic urticaria it may not be enough on its own. Adding a nasal corticosteroid in moderate to severe rhinitis gives much better results.
Pharmacokinetics
- Absorption
- Oral: rapid absorption. Peak plasma level at 1–1.5 hours. Food slightly increases absorption but not clinical efficacy.
- Distribution
- High plasma protein binding (97–99%). Wide distribution in peripheral tissues. Little penetration into the CNS: hence its low sedation.
- Metabolism
- Extensive hepatic metabolism via CYP3A4 and CYP2D6. It is converted into desloratadine, its active metabolite. Caution with CYP3A4 inhibitors (ketoconazole, erythromycin, grapefruit juice), which raise its levels.
- Elimination
- Renal and faecal, as metabolites. Half-life: 8–12 hours (loratadine) and 17–28 hours (desloratadine) → a 24-hour effect with a single daily dose.
Second-generation vs first-generation antihistamines
| Aspect | 2nd generation (loratadine) | 1st generation (diphenhydramine, dexchlorpheniramine) |
|---|---|---|
| Sedation | Minimal or none | High (crosses the blood–brain barrier) |
| Duration | 24 hours (1 dose) | 4–6 hours (3–4 doses) |
| Anticholinergic effect | Minimal | Significant (dry mouth, retention) |
| Driving | Generally compatible | Not advised |
| Use in older people | Preferable | Avoid (falls, confusion) |
| Occasional night-time use | Valid | May help because of the sedative effect |
Second generation (loratadine, cetirizine, bilastine) is the first choice in practically every case. First generation only has an advantage when sedation is the goal (insomnia from itching). In older people, always avoid the sedating ones.
Self-assessment
Three questions. When you check your answers you will see the explanation for each one.
-
First-generation antihistamines (diphenhydramine, dexchlorpheniramine) cause significant sedation and are not advised for drivers. Loratadine, cetirizine and bilastine are second generation and do not significantly affect driving.
-
Anticholinergic effects (dry mouth, urinary retention, blurred vision, constipation) are typical of first-generation antihistamines. Loratadine and other second-generation ones have minimal anticholinergic effect.
-
Clinical guidelines (ARIA) recommend adding an intranasal corticosteroid (mometasone, fluticasone) in moderate to severe allergic rhinitis. The antihistamine controls acute symptoms (itching, sneezing), but the topical corticosteroid works better on congestion and for sustained control.
Training content. It does not replace the summary of product characteristics or clinical judgement.